Cardiometabolic, Cardiovascular Complications Less Likely With Hydroxychloroquine in DLE

WEDNESDAY, June 3, 2026-- Hydroxychloroquine (HCQ) treatment for discoid lupus erythematosus (DLE) is associated with a lower risk for developing cardiovascular and cardiometabolic complications, according to a study published online April 17 in...